Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending February 2012. The document serves as a notification of transactions involving directors, persons discharging managerial responsibility (PDMR), or connected persons, specifically regarding changes in share interests.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a specific insider transaction notification and does not contain financial statements or performance metrics.
Material Changes
The filing details a specific transaction on February 17, 2012, where a connected person sold Ordinary shares to meet tax liabilities following the vesting of an award granted in 2009 under the GlaxoSmithKline Share Value Plan.
- Transaction Date: February 17, 2012
- Share Price: £14.15 per Ordinary share
- PDMR: Mr. P Thomson
- Connected Person: Mrs. K Thomson
- Shares Sold: 306
- Shares Retained: 282
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items beyond the specific insider transaction described above.
Key Facts for Investor Verification
- Verify the total shareholding of Mrs. K Thomson post-transaction to assess the significance of the sale relative to her total holdings.
- Confirm the vesting schedule and terms of the 2009 Share Value Plan award to understand the context of the tax liability.
- Check for any other concurrent insider transactions by Mr. P Thomson or other executives during the same period.